Gelebonogestrel Tablet 0.03 mg

Adult dose

First treatment cycle: From the first day of the menstrual cycle, take 1 tablet daily at a time chosen by the woman. After that, it should be taken approximately at the same time every day. If the tablet is delayed by more than 3 hours, contraceptive effectiveness may be reduced. Subsequent cycles: Continue to take the tablets daily and open a new pack to take them regardless of bleeding. Switching from combination oral contraceptives: The first tablet of this medication should be taken the day after the last active tablet of the previous combination oral contraceptive (skipping placebo tablets).

This medication should not be taken by women who are pregnant or may become pregnant. Patients with severely impaired liver function or a history of liver disease should not use this medication. Patients with blood clotting issues such as thromboembolic disease or with a history of such conditions should not take this medication. Use of this medication should be avoided if there is a tumor in the liver or a history of liver tumors. Patients with hormone-sensitive malignancies, such as breast cancer, or with a history of such conditions should not use this medication. It is advisable not to take this medication if there is unexplained abnormal vaginal bleeding. Patients with severe diabetes that causes vascular changes should consult a doctor before taking this medication. This medication should not be used if there is an allergic reaction to it or any of its ingredients. Patients with lactose intolerance or specific genetic metabolic disorders should not take this medication. Patients with hypertension, liver dysfunction, or diabetes must consult healthcare professionals before taking this medication. Caution is also necessary if there is a history of ectopic pregnancy or risks, ovarian cysts, or a history of depression. Smokers are at higher risk for cardiovascular side effects, so they should consult a doctor before taking this medication. If severe headaches, visual or auditory disturbances, symptoms of thrombosis, or liver dysfunction occur while taking this medication, stop taking it immediately and consult a healthcare professional. If surgery is planned, this medication should be discontinued at least 6 weeks prior, and should not be resumed until full ambulation has been achieved after surgery. If pregnancy is confirmed or menstrual bleeding is abnormal, this medication should be discontinued and pregnancy status should be verified. This medication may cause side effects such as breakthrough bleeding, heavy menstrual bleeding, amenorrhea, mood changes, headaches, nausea, etc. Serious side effect possibilities such as thromboembolism, stroke, liver tumors, or symptoms of diabetes should be taken into account. When taken with drugs that induce liver microsomal enzymes, the effectiveness of this medication may be reduced, leading to a risk of contraceptive failure, hence barrier contraception should be used in conjunction. Interactions with certain antibiotics, antifungals, anticonvulsants, etc. should be disclosed to healthcare professionals while taking this medication. This medication should not be used during pregnancy, and caution is needed during breastfeeding as small amounts of the drug may be transmitted through breast milk. Before starting this medication, pregnancy status should always be checked, along with thorough understanding of family and medical history. This medication is not indicated for women before menarche or after menopause. There may be a slight increase in the risk of breast cancer and the possibility of liver tumors, thus if any unusual symptoms occur, immediate consultation with healthcare professionals is necessary. If there is a history of chloasma or depression, symptoms may worsen while taking this medication, so caution is warranted. In cases of overdose, symptoms may include nausea, vomiting, and vaginal bleeding, and as there is no specific antidote, symptomatic treatment is necessary. This medication does not provide prevention for HIV or other sexually transmitted diseases, hence separate preventive measures should be utilized. During examinations, it is important to inform healthcare professionals about taking this medication as it could affect liver, thyroid, adrenal, and kidney functions. Keep out of reach of children and do not transfer to another container as it helps maintain the drug's quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, breathing abnormalities with cough and fever, jaundice (yellowing of skin or eyes), severe lethargy, sudden and severe headache, lightning headache, seizure, confusion, visual disturbances, paralysis, urinary issues

Mild side effects

• Breakthrough bleeding
• heavy menstrual bleeding
• cramps
• amenorrhea
• vaginal bleeding
• weight gain or loss
• mood changes
• migraine
• headache
• dizziness

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

White or whitish convex round sugar-coated tablet

Package unit

35 tablets/box - 35 tablets/Blister